AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16312168 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol
Number of subjects: 42
Study 16312168 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate
Number of subjects: 42
Study 12190715 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate multi-family psychoeducation groups (MFPG) plus treatment as usual (TAU)
Number of subjects: 35
Study 12190715 — intervention group
Group type: COMPARATOR
Intervention: Wait-list + treatment as usual (TAU)
Number of subjects: 35
Study 9523850 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg i.v. methylprednisolone before and saline after TDI (group 2)
Number of subjects: 65
Study 9523850 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg i.v. methylprednisolone before and after TDI (group 3)
Number of subjects: 65
Study 9523850 — intervention group
Group type: COMPARATOR
Intervention: Normal saline before and after TDI (group 1)
Number of subjects: 65
Study 7666914 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (2 mg/kg/day)
Number of subjects: 72
Study 2669346 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine sulfate 200 mg by mouth at bedtime
Number of subjects: 8
Study 2669346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 1089885 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte transfusion obtained from a single donor each day for four days
Number of subjects: 36
Study 1089885 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 36
Study 30048511 — intervention group
Group type: EXPERIMENTAL
Intervention: serious gaming only
Number of subjects: 120
Study 30048511 — intervention group
Group type: EXPERIMENTAL
Intervention: verbal suggestions only
Number of subjects: 120
Study 30048511 — intervention group
Group type: EXPERIMENTAL
Intervention: serious gaming combined with verbal suggestions
Number of subjects: 120
Study 30048511 — intervention group
Group type: COMPARATOR
Intervention: gaming control condition
Number of subjects: 120
Study 25043636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmicort Turbuhaler (DPI)
Number of subjects: 36
Study 25043636 — intervention group
Group type: COMPARATOR
Intervention: Aeronide inhaler (pMDI)
Number of subjects: 36
Study 24526136 — intervention group
Group type: EXPERIMENTAL
Intervention: 33 μg/kg/day growth hormone (GH) for 260 weeks
Number of subjects: 65
Study 24526136 — intervention group
Group type: EXPERIMENTAL
Intervention: 67 μg/kg/day growth hormone (GH) for 260 weeks
Number of subjects: 65
Study 23047085 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management program (3 hours)
Number of subjects: 55
Study 23047085 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group
Number of subjects: 55
Study 23047085 — intervention group
Group type: EXPERIMENTAL
Intervention: First group of the stress management program
Number of subjects: 55
Study 23047085 — intervention group
Group type: EXPERIMENTAL
Intervention: Second group of the stress management program
Number of subjects: 55
Study 23047085 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management intervention
Number of subjects: 55
Study 20140250 — intervention group
Group type: COMPARATOR
Intervention: oleic acid
Number of subjects: 61
Study 20140250 — intervention group
Group type: COMPARATOR
Intervention: industrial trans fatty acids
Number of subjects: 61
Study 20140250 — intervention group
Group type: COMPARATOR
Intervention: 80% cis‐9, trans‐11 and 20% trans‐10, cis‐12 CLA
Number of subjects: 61
Study 18568968 — intervention group
Group type: EXPERIMENTAL
Intervention: Operational motion of the thumb
Number of subjects: 15
Study 18568968 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumduction of the thumb
Number of subjects: 15
Study 16599106 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-use therapeutic food (RUTF)
Number of subjects: 372
Study 16599106 — intervention group
Group type: COMPARATOR
Intervention: Micronutrient-fortified corn/soy-blend
Number of subjects: 372
Study 14721990 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 65
Study 14721990 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 65
Study 10982756 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg daily)
Number of subjects: 32
Study 10982756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8791975 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate gel (1 g b.d.)
Number of subjects: 141
Study 8791975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 1292969 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine (900 mg/day for two weeks)
Number of subjects: 24
Study 1292969 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdosteine (pre-incubation before smoke exposure)
Number of subjects: 24
Study 1292969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 6712032 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg orally twice a day for 7 days
Number of subjects: 29
Study 6712032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 31511705 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual intervertebral foramen opening technique
Number of subjects: 40
Study 31511705 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual traction of cervical spine
Number of subjects: 40
Study 31511705 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both techniques
Number of subjects: 40
Study 31511705 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 29898348 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program based on Health Belief Model (HBM)
Number of subjects: 120
Study 29898348 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 120
Study 26514967 — intervention group
Group type: EXPERIMENTAL
Intervention: OXC + verapamil (300 mg OXC/12 h and 80 mg verapamil/8 h for 5 days)
Number of subjects: 12
Study 26514967 — intervention group
Group type: COMPARATOR
Intervention: OXC monotherapy (300 mg OXC/12 h for 5 days)
Number of subjects: 12
Study 24481580 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg dexketoprofen (GD)
Number of subjects: 120
Study 24481580 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg lornoxicam (GL)
Number of subjects: 120
Study 24481580 — intervention group
Group type: COMPARATOR
Intervention: Saline as placebo (GP)
Number of subjects: 120
Study 22713851 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical intervention (Study 1, n=22, 3 weeks duration, two sessions per week)
Number of subjects: 33
Study 22713851 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical intervention (Study 2, n=11, evaluation 2 and 4 weeks after intervention)
Number of subjects: 33
Study 22713851 — intervention group
Group type: COMPARATOR
Intervention: Painting intervention (Study 1)
Number of subjects: 33
Study 22713851 — intervention group
Group type: COMPARATOR
Intervention: Cooking intervention (Study 2)
Number of subjects: 33
Study 20169301 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% tacrolimus ointment
Number of subjects: 80
Study 20169301 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid regimen (hydrocortisone acetate 1% ointment for head and neck, hydrocortisone butyrate 0.1% ointment for trunk and limbs)
Number of subjects: 80
Study 20169301 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid regimen
Number of subjects: 80
Study 17570057 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of Divalproex sodium (DVP)
Number of subjects: 71
Study 17570057 — intervention group
Group type: COMPARATOR
Intervention: Low dose of Divalproex sodium (DVP)
Number of subjects: 71
Study 17570057 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex sodium (DVP)
Number of subjects: 71
Study 16251796 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal and postnatal fluoride supplements
Number of subjects: 185
Study 16251796 — intervention group
Group type: COMPARATOR
Intervention: Postnatal fluoride only
Number of subjects: 185
Study 12010875 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg
Number of subjects: 17
Study 12010875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 11045181 — intervention group
Group type: COMPARATOR
Intervention: Fluvastatin 40 mg daily
Number of subjects: 104
Study 11045181 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fluvastatin (20 mg daily) and fenofibrate (200 mg daily)
Number of subjects: 104
Study 8736279 — intervention group
Group type: EXPERIMENTAL
Intervention: Full replacement therapy (thyroxine)
Number of subjects: 10
Study 8736279 — intervention group
Group type: COMPARATOR
Intervention: 50 micrograms thyroxine daily for 2 weeks
Number of subjects: 10
Study 8736279 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline infusion at 25 ng/kg/min for 30 minutes
Number of subjects: 10
Study 8736279 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline infusion
Number of subjects: 10
Study 1895900 — intervention group
Group type: EXPERIMENTAL
Intervention: OTM-01A ophthalmic tonometer
Number of subjects: 42
Study 1895900 — intervention group
Group type: COMPARATOR
Intervention: Goldman's tonometer
Number of subjects: 42
Study 6624778 — intervention group
Group type: COMPARATOR
Intervention: Aerosol albuterol (3 puffs)
Number of subjects: 17
Study 6624778 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aminophylline (400 mg) and terbutaline sulfate (5 mg)
Number of subjects: 17
Study 6624778 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral therapy
Number of subjects: 17
Study 30700324 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent retrospective continuous glucose monitoring (r-CGM)
Number of subjects: 0
Study 30700324 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27610741 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular evidence-based treatment targeting comorbid mental health problems
Number of subjects: 57
Study 27610741 — intervention group
Group type: COMPARATOR
Intervention: Modular evidence-based treatment focusing on principal clinical problems
Number of subjects: 57
Study 26986774 — intervention group
Group type: EXPERIMENTAL
Intervention: SAX technique (n=25)
Number of subjects: 101
Study 26986774 — intervention group
Group type: EXPERIMENTAL
Intervention: LAX technique (n=26)
Number of subjects: 101
Study 22917623 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive trials with monetary reward for correct performance
Number of subjects: 63
Study 22917623 — intervention group
Group type: COMPARATOR
Intervention: No-incentive trials without monetary reward
Number of subjects: 63
Study 22917623 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher glucocorticoid (GC) dosage
Number of subjects: 63
Study 21791470 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of MAGEA6 and CDCA1
Number of subjects: 584
Study 21791470 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of MAGEA9
Number of subjects: 584
Study 21791470 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of CTAG2
Number of subjects: 584
Study 21791470 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of SSX1
Number of subjects: 584
Study 18990168 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 3000
Study 18990168 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 3000
Study 18990168 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 3000
Study 18990168 — intervention group
Group type: COMPARATOR
Intervention: Hormone therapy (control)
Number of subjects: 3000
Study 16846539 — intervention group
Group type: EXPERIMENTAL
Intervention: Global risk educational tool
Number of subjects: 368
Study 16846539 — intervention group
Group type: COMPARATOR
Intervention: General information on coronary prevention goals and strategies (Control)
Number of subjects: 368
Study 12766755 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 317
Study 12766755 — intervention group
Group type: COMPARATOR
Intervention: Atenolol and hydrochlorothiazide (as adjunct therapy)
Number of subjects: 317
Study 10699773 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous carbon dioxide (PtcCO(2)) monitoring guiding sedation (Group 1)
Number of subjects: 395
Study 10699773 — intervention group
Group type: COMPARATOR
Intervention: Control group with PtcCO(2) recorded but not used for guiding sedation (Group 2)
Number of subjects: 395
Study 9327366 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray-dried bovine serum concentrate (25% replacement of milk protein)
Number of subjects: 10
Study 9327366 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray-dried bovine serum concentrate (50% replacement of milk protein)
Number of subjects: 10
Study 9327366 — intervention group
Group type: COMPARATOR
Intervention: Control diet (rice, milk, vegetable oil, and sugar)
Number of subjects: 10
Study 9327366 — intervention group
Group type: EXPERIMENTAL
Intervention: Spray-dried bovine serum concentrate (25% and 50% replacement)
Number of subjects: 10
Study 8227760 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (800 mg) during dexamethasone and postdexamethasone days
Number of subjects: 35
Study 8227760 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone suppression test (DST)
Number of subjects: 35
Study 8227760 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram-potentiated DST (DSTd)
Number of subjects: 35
Study 3533256 — intervention group
Group type: EXPERIMENTAL
Intervention: Bestatin
Number of subjects: 101
Study 3533256 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 101
Study 31339403 — intervention group
Group type: EXPERIMENTAL
Intervention: Group‐task‐oriented training (group‐TOT) for 1 hour, twice a week for 8 weeks
Number of subjects: 18
Study 31339403 — intervention group
Group type: COMPARATOR
Intervention: Individualized traditional physical and occupational therapy (comparison group)
Number of subjects: 18
Study 29105252 — intervention group
Group type: EXPERIMENTAL
Intervention: New information resource
Number of subjects: 80
Study 29105252 — intervention group
Group type: COMPARATOR
Intervention: Service as usual
Number of subjects: 80
Study 27544584 — intervention group
Group type: EXPERIMENTAL
Intervention: qHPV vaccine (0.5mL) administered intramuscularly at months 0, 2, and 6
Number of subjects: 372
Study 27544584 — intervention group
Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 372
Study 24871666 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat bran-inclusive diet
Number of subjects: 0
Study 24871666 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study 22736125 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 day of bowel preparation
Number of subjects: 60
Study 22736125 — intervention group
Group type: COMPARATOR
Intervention: 3 days of bowel preparation
Number of subjects: 60
Study 20441133 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported evaluations of problem seriousness, help-seeking importance, and prognosis when imagining oneself with depressive symptoms.
Number of subjects: 263
Study 20441133 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported evaluations of problem seriousness, help-seeking importance, and prognosis when imagining a peer-group friend with depressive symptoms.
Number of subjects: 263
Study 20441133 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual effect of symptom severity presentation.
Number of subjects: 263
Study 18676533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod liver oil (10 mL daily from week 18 of pregnancy until 3 months after delivery)
Number of subjects: 143
Study 18676533 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (10 mL daily from week 18 of pregnancy until 3 months after delivery)
Number of subjects: 143
Study 18676533 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma phospholipid concentrations of alpha-linolenic acid and docosahexaenoic acid during pregnancy
Number of subjects: 143
Study 18676533 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty acid status at birth or during the first 3 months of life
Number of subjects: 143
Study 18334948 — intervention group
Group type: EXPERIMENTAL
Intervention: lotrafilcon B (O2 Optix) with AQuify and ReNu MoistureLoc
Number of subjects: 48
Study 18334948 — intervention group
Group type: EXPERIMENTAL
Intervention: galyfilcon A (Acuvue Advance) with AQuify and ReNu MoistureLoc
Number of subjects: 48
Study 18334948 — intervention group
Group type: EXPERIMENTAL
Intervention: Both lens materials
Number of subjects: 48
Study 15161072 — intervention group
Group type: EXPERIMENTAL
Intervention: IPV(vero)
Number of subjects: 129
Study 15161072 — intervention group
Group type: COMPARATOR
Intervention: IPV(mkc)
Number of subjects: 129
Study 9271616 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Well Child Care (GWCC)
Number of subjects: 210
Study 9271616 — intervention group
Group type: COMPARATOR
Intervention: Individual Well Child Care (IWCC)
Number of subjects: 210
Study 9271616 — intervention group
Group type: EXPERIMENTAL
Intervention: Both GWCC and IWCC
Number of subjects: 210
Study 7896932 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of attitudes and beliefs regarding clinical judgment research
Number of subjects: 0
Study 7896932 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of knowledge of clinical judgment literature
Number of subjects: 0
Study 7896932 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey on the importance of clinical judgment research
Number of subjects: 0
Study 3657165 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence for 3 weeks
Number of subjects: 60
Study 3657165 — intervention group
Group type: COMPARATOR
Intervention: Continued drinking as usual
Number of subjects: 60
Study 30900065 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors of non-pulmonary cancers developing SPLC
Number of subjects: 1450837
Study 30900065 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors of cancer of the hypopharynx, oropharynx, tonsil, and larynx
Number of subjects: 1450837
Study 30900065 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors of bladder and esophageal cancer
Number of subjects: 1450837
Study 30900065 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing age and being divorced/widowed/separated
Number of subjects: 1450837
Study 30900065 — intervention group
Group type: COMPARATOR
Intervention: Comparison with control arm of the NLST
Number of subjects: 1450837
Study 30526779 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified brain protection double-lumen drainage tube
Number of subjects: 49
Study 30526779 — intervention group
Group type: COMPARATOR
Intervention: Traditional silicone drainage tube
Number of subjects: 49
Study 26957375 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care with >8 months in the PCMH
Number of subjects: 4664
Study 26957375 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated mailed and centrally delivered stepped interventions
Number of subjects: 4664
Study 26957375 — intervention group
Group type: COMPARATOR
Intervention: Usual care with <4 months in the PCMH
Number of subjects: 4664
Study 24874315 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761 (240 mg per day for 24 weeks)
Number of subjects: 45
Study 24874315 — intervention group
Group type: COMPARATOR
Intervention: Other drugs (control group)
Number of subjects: 45
Study 22365947 — intervention group
Group type: EXPERIMENTAL
Intervention: Azosemide (long-acting loop diuretic)
Number of subjects: 98
Study 22365947 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (short-acting loop diuretic)
Number of subjects: 98
Study 22365947 — intervention group
Group type: COMPARATOR
Intervention: Echocardiography and chest X-ray
Number of subjects: 98
Study 20801763 — intervention group
Group type: EXPERIMENTAL
Intervention: MR spectroscopy in PMA
Number of subjects: 60
Study 20801763 — intervention group
Group type: COMPARATOR
Intervention: MR spectroscopy in PLS
Number of subjects: 60
Study 20801763 — intervention group
Group type: COMPARATOR
Intervention: MR spectroscopy in ALS-L and ALS-B
Number of subjects: 60
Study 20801763 — intervention group
Group type: COMPARATOR
Intervention: MR spectroscopy in all groups
Number of subjects: 60
Study 20801763 — intervention group
Group type: COMPARATOR
Intervention: NAAx and mIns levels
Number of subjects: 60
Study 18300446 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour pH monitoring with antacid treatment (omeprazole)
Number of subjects: 50
Study 18300446 — intervention group
Group type: COMPARATOR
Intervention: Control group with antacid treatment (omeprazole) only
Number of subjects: 50
Study 16273995 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 0
Study 12174378 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvianolic acid B (SA‐B)
Number of subjects: 60
Study 12174378 — intervention group
Group type: COMPARATOR
Intervention: Interferon‐gamma (IFN‐gamma)
Number of subjects: 60
Study 10450010 — intervention group
Group type: EXPERIMENTAL
Intervention: Bardex IC catheter
Number of subjects: 198
Study 10450010 — intervention group
Group type: COMPARATOR
Intervention: Silicon catheter
Number of subjects: 198
Study 10450010 — intervention group
Group type: COMPARATOR
Intervention: Latex catheter
Number of subjects: 198
Study 2533866 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms of B‐Hepavac II vaccine
Number of subjects: 84
Study 2533866 — intervention group
Group type: COMPARATOR
Intervention: 5 micrograms of B‐Hepavac II vaccine
Number of subjects: 84
Study 779705 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadyl acetate (80 mg three times a week)
Number of subjects: 430
Study 779705 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methadone (50 mg daily or 100 mg daily)
Number of subjects: 430
Study 779705 — intervention group
Group type: COMPARATOR
Intervention: Low-dose methadone
Number of subjects: 430
Study 31464393 — intervention group
Group type: EXPERIMENTAL
Intervention: Original Riceberry rice pudding
Number of subjects: 12
Study 31464393 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fiber Riceberry rice pudding
Number of subjects: 12
Study 31464393 — intervention group
Group type: COMPARATOR
Intervention: White bread (control)
Number of subjects: 12
Study 28472530 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention for 3 months with individualized nutrition care plan plus monthly post-discharge telehealth follow-up
Number of subjects: 148